International Federation of Pharmaceutical Manufacturers & Association (IFPMA)2019-09-252019-09-252014-12-182006http://hdl.handle.net/20.500.12424/216116The IFPMA Code of Pharmaceutical Marketing Practices (the “IFPMA Code”) sets forth standards for the ethical promotion of pharmaceutical products to healthcare professionals, and for member companies’ interactions with them. Effective January 1st, 2007, this Code replaces the IFPMA Code of Pharmaceutical Marketing Practices (Update 2000). Member associations of IFPMA must incorporate this Code into existing national codes no later than January 1st, 2007, subject to the guidance set out in articles (vi) and (vii) below. (iv) IFPMA acknowledges the role of relevant codes of ethics developed by the World Medical Association, International Council of Nurses and the International Federation of Pharmacists. IFPMA also recognizes the role of Ethical Criteria for Medicinal Drug Promotion provided by the World Health Organization in 1988. (v) The IFPMA Code contains provisions relating to scope, applicability and guiding principles (Articles 1-2), the content of promotional material (Articles 3-6); interactions with healthcare professionals (Articles 7-8); company procedures and responsibilities (Article 9); and operation and enforcement (Article 10). (Appendix 1) (Preamble)engWith permission of the license/copyright holdercode of ethicscode of conducthealthcare professionalspharmaceutical productsmarketing practicesdrug promotionInternational Federation of Pharmaceutical ManufacturersBioethicsMedical ethicsHealth ethicsPreprint